全球经导管主动脉瓣置换术 (TAVR) 市场 - 市场规模（按细分市场）、份额、监管、报销、程序、预测（~2033 年）

经导管主动脉瓣置换术适用于老年患者和严重症状的主动脉瓣狭窄且手术风险较高的患者。 由于人口结构的变化，主动脉瓣狭窄患者的数量正在稳定增加。 虽然主动脉瓣置换术仍然是黄金标准治疗，但经导管主动脉瓣置换术（也称为经导管主动脉瓣植入术）是不能手术的老年患者和手术风险高的患者的一种替代疗法。其作为手术主动脉瓣植入术的替代方案的适用性正在研究中。由于其手术和恢復时间短而受到研究。

本报告研究和分析了全球经导管主动脉瓣置换术 (TAVR) 市场，并提供了有关每个细分市场的市场规模、市场趋势、竞争格局以及 COVID-19 影响的资讯。

市场模型的主要内容如下。

已上市的经导管主动脉瓣置换术 (TAVR) 和不断变化的竞争格局

• 对主要产业趋势的考虑
• 经导管主动脉瓣置换术 (TAVR) 市场年收入和市场前景（按细分市场）（2015-2033 年）
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域和国家层面的特定市场考量

• 按地区细分全球趋势的特定市场定性资讯和国家/地区考虑因素
• 经导管主动脉瓣置换术 (TAVR) 市场的 SWOT 分析
• 经导管主动脉瓣置换术 (TAVR) 市场竞争动态的考量与趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。 市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技监理状况

目标公司

• Edwards Lifesciences
• Medtronic Plc
• Abbott Laboratories
• Boston Scientific Corp
• MicroPort Scientific Corp
• 其他

Abstract

Transcatheter Aortic Valve Replacement (TAVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Transcatheter Aortic Valve Replacement (TAVR) market for the year 2020 and beyond. Transcatheter aortic valve implantation is used in patients who are elderly or are at a high risk for surgery and have severe symptomatic aortic valve stenosis. The number of patients who suffer from aortic stenosis is steadily increasing due to changing demographics. While aortic valve replacement remains the gold standard therapy, transcatheter aortic valve Replacement, also known as transcatheter aortic valve implantation has been identified as an alternative in elderly patients, inoperable or of higher surgical risk, and its suitability as a replacement for surgical aortic valve implantation is being explored due to lower operation and recovery times. Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitonol stent. These valves can be either balloon expandable or self expandable.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Aortic Valve Replacement Devices (TAVR) and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Transcatheter Aortic Valve Replacement (TAVR) Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Transcatheter Aortic Valve Replacement (TAVR) Devices market.
• Competitive dynamics insights and trends provided for Transcatheter Aortic Valve Replacement (TAVR) Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Edwards Lifesciences, Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, MicroPort Scientific Corp, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Transcatheter Aortic Valve Replacement (TAVR) Systems marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Transcatheter Aortic Valve Replacement (TAVR) market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Transcatheter Aortic Valve Replacement (TAVR) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Aortic Valve Replacement (TAVR) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Transcatheter Aortic Valve Replacement (TAVR) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable